Download PDF
Psychiatr Prax 2018; 45(07): 347-357
DOI: 10.1055/a-0677-7301
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Die Effekte nicht-pharmakologischer, gesundheitsfördernder Interventionen bei Menschen mit schweren psychischen Erkrankungen

Ein systematischer LiteraturüberblickThe Impact of Non-Pharmacologic Lifestyle Interventions in People with Severe Mental IllnessA Systematic Review
Daniel Richter
1   Institut für Qualitätssicherung und Transparenz im Gesundheitswesen (IQTIG), Berlin
2   Institut für Sozialmedizin, Arbeitsmedizin und Public Health (ISAP), Universität Leipzig
,
Uta Gühne
2   Institut für Sozialmedizin, Arbeitsmedizin und Public Health (ISAP), Universität Leipzig
,
Janine Stein
2   Institut für Sozialmedizin, Arbeitsmedizin und Public Health (ISAP), Universität Leipzig
,
Stefan Weinmann
3   Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Vivantes Klinikum Am Urban, Berlin
,
Thomas Becker
4   Klinik für Psychiatrie und Psychotherapie II der Universität Ulm, Bezirkskrankenhaus Günzburg
,
Steffi G. Riedel-Heller
2   Institut für Sozialmedizin, Arbeitsmedizin und Public Health (ISAP), Universität Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
10 October 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund Menschen mit schweren psychischen Erkrankungen sind deutlichen Risiken somatischer Morbidität und erhöhter Mortalität ausgesetzt. Gesundheitsfördernde Interventionen sollen die Risiken dafür reduzieren. Die Arbeit trägt die Evidenz in diesem Bereich zusammen.

Methodik Systematische Suche in Medline, EMBASE, PsycINFO und der Cochrane Library nach Übersichtsarbeiten und RCTs.

Ergebnisse Gesundheitsfördernde Interventionen zeigten nahezu durchweg positive Effekte in Bezug auf die untersuchten Parameter.

Schlussfolgerung Weitere nachhaltige Untersuchungen sind erforderlich.

Abstract

Background In recent years public and research interests focused more and more in lifestyle as a key factor for health. Particularly lifestyle of people with severe mental illness in combination with modifiable risk factors and adverse effects of the antipsychotic medication is especially critical. The present paper investigated the effect of multimodal healthy lifestyle interventions concerning weight and BMI reduction.

Methods We systematically searched electronic databases (Medline, EMBASE, PsycINFO, Cochrane Library) for reviews and RCTs.

Results Six systematic reviews and three single RCTs met inclusion criteria. Analyzed lifestyle interventions, mostly combined approaches of nutrition and sports, showed short and medium term effects in weight and BMI reduction compared with controls.

Conclusion Lifestyle interventions appear effective for treating overweight among people with serious mental illness. Further research is needed for evaluating long-term effects of the lifestyle interventions as well as focusing special components of the interventions with especially high user benefit.

Schlüsselwörter

Lebensstil - schwere psychische Erkrankungen

Keywords

lifestyle - severe mental illness

Die Tab. 2, 4 und 7 sowie die Abb. 2 und 3 finden Sie unter https://doi.org/10.1055/a-0677-7301

 

  • Literatur

  • 1 Mahmood S, Levy D, Vasan R. et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. The Lancet 2014; 383: 999-1008
    CrossrefPubMedGoogle Scholar
  • 2 Schienkiewitz A, Walter U. Glossar. In: Schwartz F. et al. Das Public Health Buch. Gesundheit und Gesundheitswesen. 2.. Auflage. München: Urban & Fischer; 2003: 805-829
    Google Scholar
  • 3 Abel T. Gesundheitsrelevante Lebensstile. In: Maeder C. et al. Gesundheit, Medizin und Gesellschaft: Beiträge zur Soziologie der Gesundheit. Zürich: Seismo-Verlag; 1999: 43-61
    Google Scholar
  • 4 Dunn AL, Anderson RE, Jakicic JM. Life-style physical activity interventions: history, short and long term effects and recommendations. Am J Preven Med 1998; 15: 398-412
    PubMedGoogle Scholar
  • 5 Hackshaw A, Morris JK, Boniface S. et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ 2018; 360: j5855
    CrossrefPubMedGoogle Scholar
  • 6 Wippermann C. Lebensstile und Milieus: Einflüsse auf die Gesundheit. In: Schumpelick V, Vogel B. Hrsg. Volkskrankheiten. Freiburg im Breisgau: Herder; 2009: 143-156
    Google Scholar
  • 7 Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry 2006; 14: 212-222
    CrossrefPubMedGoogle Scholar
  • 8 Richardson CR, Faulkner G, McDevitt J. et al. Integrating physical activity into mental health services for persons with serious mental illness. Psychiatric Services 2005; 56: 324-331
    CrossrefPubMedGoogle Scholar
  • 9 American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists. Consensus development conference on antipsychotic drugs and obesity and diabetes. Journal of Clinical Psychiatry 2004; 65: 267-272
    CrossrefPubMedGoogle Scholar
  • 10 Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry 2011; 68: 609-616
    CrossrefPubMedGoogle Scholar
  • 11 Newcomer JW, Wieden PJ, Buchanan RW. Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice. Journal of Clinical Psychiatry 2013; 74: 1108-1120
    CrossrefPubMedGoogle Scholar
  • 12 Dickerson FB, Brown CH, Kreyenbuhl JA. et al. Obesity among individuals with serious mental illness. Acta Psychiatr Scand 2006; 113: 306-313
    CrossrefPubMedGoogle Scholar
  • 13 Allison DB, Newcomer JW, Dunn AL. et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 2009; 36: 341-350
    CrossrefPubMedGoogle Scholar
  • 14 Daumit GL, Clark JM, Steinwachs DM. et al. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis 2003; 191: 799-805
    CrossrefPubMedGoogle Scholar
  • 15 Leucht S, Burkard T, Henderson J. et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007; 116: 317-333
    CrossrefPubMedGoogle Scholar
  • 16 Deutsche Gesellschaft für Adipositas. BMI Klassifikation. (nach WHO, 2000). Im Internet unter: http://www.adipositas-gesellschaft.de/index.php?id=39 (Stand: 21.02.2018)
    Google Scholar
  • 17 Leucht S, Corves C, Arbter D. et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a metaanalysis. Lancet 2009; 373: 31-41
    CrossrefPubMedGoogle Scholar
  • 18 Holt RI, Peveler RC. Association between antipsychotic drugs and diabetes. Diabetes Obes Metab 2006; 8: 125-135
    CrossrefPubMedGoogle Scholar
  • 19 Bushe C, Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br J Psychiatry 2004; 47: 67-71
    PubMedGoogle Scholar
  • 20 McIntyre RS, Konarski JZ, Misener VL. et al. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005; 17: 83-93
    CrossrefPubMedGoogle Scholar
  • 21 van Winkel R, De Hert M, Van Eyck D. et al. Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods. J Clin Psychiatry 2006; 67: 1493-1500
    CrossrefPubMedGoogle Scholar
  • 22 Barnett AH, Mackin P, Chaudhry I. et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol 2007; 21: 357-373
    CrossrefPubMedGoogle Scholar
  • 23 van Winkel R, De Hert M, Van Eyck D. et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008; 10: 342-348
    CrossrefPubMedGoogle Scholar
  • 24 Regenold WT, Thapar RK, Marano C. et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002; 70: 19-26
    CrossrefPubMedGoogle Scholar
  • 25 De Hert M, Mauri M, Shaw K. et al. The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology. Int J Methods Psychiatr Res 2010; 19: 195-210
    CrossrefPubMedGoogle Scholar
  • 26 De Hert M, van Winkel R, Van Eyck D. et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health 2006; 2: 14
    CrossrefPubMedGoogle Scholar
  • 27 Arroyo C, Hu FB, Ryan LM. et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 129-133
    CrossrefPubMedGoogle Scholar
  • 28 Brown LC, Majumdar SR, Newman SC. et al. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care 2005; 28: 1063-1067
    CrossrefPubMedGoogle Scholar
  • 29 Carnethon MR, Kinder LS, Fair JM. et al. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992. Am J Epidemiol 2003; 158: 416-423
    CrossrefPubMedGoogle Scholar
  • 30 Eaton WW, Armenian H, Gallo J. et al. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097-1102
    CrossrefPubMedGoogle Scholar
  • 31 Everson-Rose SA, Meyer PM, Powell LH. et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27: 2856-2862
    CrossrefPubMedGoogle Scholar
  • 32 Golden SH, Williams JE, Ford DE. et al. Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004; 27: 429-435
    CrossrefPubMedGoogle Scholar
  • 33 Kawakami N, Takatsuka N, Shimizu H. et al. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22: 1071-1076
    CrossrefPubMedGoogle Scholar
  • 34 Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 2004; 21: 1185-1191
    CrossrefPubMedGoogle Scholar
  • 35 van den Akker M, Schuurman A, Metsemakers J. et al. Is depression related to subsequent diabetes mellitus?. Acta Psychiatr Scand 2004; 110: 178-183
    CrossrefPubMedGoogle Scholar
  • 36 Hennekens CH, Hennekens AR, Hollar D. et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150: 1115-1121
    CrossrefPubMedGoogle Scholar
  • 37 Osborn DP, Levy G, Nazareth I. et al. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database. Arch Gen Psychiatry 2007; 64: 242-249
    CrossrefPubMedGoogle Scholar
  • 38 Goff DC, Sullivan LM, McEvoy JP. et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005; 80: 45-53
    CrossrefPubMedGoogle Scholar
  • 39 Kisely S, Campbell LA, Wang Y. Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatry 2009; 195: 545-550
    CrossrefPubMedGoogle Scholar
  • 40 Kisely S, Smith M, Lawrence D. et al. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ 2007; 176: 779-784
    CrossrefPubMedGoogle Scholar
  • 41 Bresee LC, Majumdar SR, Patten SB. et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 2010; 117: 75-82
    CrossrefPubMedGoogle Scholar
  • 42 Lin HC, Hsiao FH, Pfeiffer S. et al. An increased risk of stroke among young schizophrenia patients. Schizophr Res 2008; 101: 234-241
    CrossrefPubMedGoogle Scholar
  • 43 Curkendall SM, Mo J, Glasser DB. et al. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004; 65: 715-720
    CrossrefPubMedGoogle Scholar
  • 44 Lin HC, Tsai SY, Lee HC. Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: a six-year Follow-up study. J Affect Disord 2007; 100: 49-54
    CrossrefPubMedGoogle Scholar
  • 45 Millar H. Management of physical health in schizophrenia: a stepping stone to treatment success. Eur Neuropsychopharmacol 2008; 18: S121-128
    CrossrefPubMedGoogle Scholar
  • 46 WHO. Premature death among people with severe mental disorders. Genf: 2007
    Google Scholar
  • 47 Jayatilleke N. Contributions of specific causes of death to lost life expectancy in severe mental illness. European Psychiatry 2017; 43: 109-115
    CrossrefPubMedGoogle Scholar
  • 48 Prince M, Patel V, Saxena S. et al. No health without mental health. Lancet 2007; 370: 859-877
    CrossrefPubMedGoogle Scholar
  • 49 Teychenne M, Ball K, Salmon J. Physical activity and likelihood of depression in adults: a review. Prev Med 2008; 46: 397-411
    CrossrefPubMedGoogle Scholar
  • 50 Jacka FN, Pasco JA, Mykletun A. et al. Association of western and traditional diets with depression and anxiety in women. Am J Psychiatry 2010; 167: 305-311
    CrossrefPubMedGoogle Scholar
  • 51 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009; 6: e1000097
    CrossrefPubMedGoogle Scholar
  • 52 Cochrane Deutschland, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Bewertung von systematischen Übersichtsarbeiten: ein Manual für die Leitlinienerstellung. 1.. Auflage. Institut für Medizinisches Wissensmanagement; 2017
    Google Scholar
  • 53 Shea BJ, Bouter LM, Peterson J. et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). PloS One 2007; 2: e1350
    CrossrefPubMedGoogle Scholar
  • 54 The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0: TheCochraneCollaboration. 2011. [cited 2016 22.03.2016]. Available from: http://handbook.cochrane.org/chapter_8/table_8_5_a_the_cochrane_collaborations_tool_for_assessing.htm
    Google Scholar
  • 55 Bruins J, Jörg F, Bruggeman R. et al. The Effects of Lifestyle Interventions on (Long-Term) Weight Management, Cardiometabolic Risk and Depressive Symptoms in People with Psychotic Disorders: A Meta-Analysis. PLoS ONE 2014; 9 e112276. DOI: https://doi.org/10.1371/journal.pone.0112276.
    CrossrefPubMedGoogle Scholar
  • 56 Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials. Schizophr Res 2012; 140: 159-168
    CrossrefPubMedGoogle Scholar
  • 57 Bonfioli E, Berti L, Goss C. et al. Health promotion lifestyle interventions for weight management in psychosis: A systematic review and meta- analysis of randomised controlled trials. BMC Psychiatry 2012; 12: 2-12
    CrossrefPubMedGoogle Scholar
  • 58 Álvarez-Jiménez M, Hetrick S, González-Blanch C. et al. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. The British Journal of Psychiatry 2008; 193: 101-107
    CrossrefPubMedGoogle Scholar
  • 59 Fernández-San M, López M, Masa-Font R. et al. The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies. Community Ment Health J 2014; 50: 81-95
    CrossrefPubMedGoogle Scholar
  • 60 Faulkner G, Soundy AA, Lloyd K. Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinarvica 2003; 108: 324-332
    PubMedGoogle Scholar
  • 61 Green CA, Yarborough BJ, Leo MC. et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry 2015; 172: 71-81
    CrossrefPubMedGoogle Scholar
  • 62 Gillhoff K, Gaab J, Emini L. et al. Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial. Prim Care Companion J Clin Psychiatry 2010 12. PCC.09m00906
    PubMedGoogle Scholar
  • 63 Masa-Font R, Fernández-San M, López LM. et al. The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness after 3-month Follow-up: CAPiCOR randomized clinical trial. European Psychiatry 2015; 30: 1028-1036
    PubMedGoogle Scholar
  • 64 Naslund J, Whiteman K, McHugo G. et al. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis. Gen Hosp Psychiatry 2017; 47: 83-102
    CrossrefPubMedGoogle Scholar
  • 65 National Institute for Health and Care Excellence. Guideline „Psychosis and schizophrenia in adults: prevention and management“. 2014
    Google Scholar
  • 66 Scottish Intercollegiate Guidelines Network. Guideline „Management of schizophrenia“. 2013
    Google Scholar
  • 67 Soundy A, Freeman P, Stubbs B. et al. The transcending benefits of physical activity for individuals with schizophrenia: A systematic review and meta-ethnography. Psychiatry Res 2014; 220: 11-19
    CrossrefPubMedGoogle Scholar
  • 68 Farholm A, Sorensen M. Motivation for physical activity and exercise in severe mental illness: A systematic review of intervention studies. Int J Ment Health Nursing 2016; 25: 194-205
    PubMedGoogle Scholar
  • 69 Firth J, Rosenbaum S, Stubbs B. et al. Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychol Med 2016; 46: 2869-2881
    CrossrefPubMedGoogle Scholar
  • 70 Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen. 1. Update. Springer; 2018. in Druck
    Google Scholar
  • 71 Häfner S, Wolff-Menzler C, Schulz M. et al. Diagnosis of Metabolic Risk Factors in Psychiatric Inpatients. Psychiat Prax 2016; 43: 312-317
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 Fink A, Cieslak S, Rosenbach F. Non-Pharmacological Interventions for the Prevention of Weight Gain in Schizophrenic Patients Treated with Antipsychotic Medication Systematic Review and Meta-Analysis. Psychiat Prax 2015; 42: 359-369
    Article in Thieme ConnectPubMedGoogle Scholar
  • 73 Krausz RM. Die systemische und die subjektive Seite der Schizophrenie oder wie weit weg sind wir von einer patientenorientierten Psychiatrie?. Psychiat Prax 2017; 44: 188-189
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Gühne U, Weinmann S, Becker T. et al. Die S3-Leitlinie „Psychosoziale Therapien bei schweren psychischen Erkrankungen“ – nach dem Update ist vor dem Update. Psychiat Prax 2018; 45: 119-121
    Article in Thieme ConnectPubMedGoogle Scholar